PC3I News
A new $4.9 million grant has been awarded to the Perelman School of Medicine at the University of Pennsylvania to use behavioral economics and implementation science to improve the uptake of evidence-based practices in cancer care. Penn Center for Cancer Care Innovation (PC3I) Director Justin E. Bekelman, MD, will serve as one of three principal investigators (PIs) leading this project along with PC3I Advisory Group members Rinad Beidas, PhD, and Robert A. Schnoll, PhD. The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is funding the work through a P50 grant over five years. The award, part of the Cancer Moonshot Initiative, makes Penn one of seven centers across the country working on this effort as part of the NCI’s Implementation Science Centers in Cancer Control.
The team, which brings together experts from across Penn, also includes PC3I Faculty Katharine Rendle, PhD, MSW, MPH; Samuel Takvorian, MD, MS; and Peter Gabriel, MD, MSE; as well as PC3I Affiliates David Asch, MD, MBA; Frances Barg, PhD, MEd; Frank Leone, MD, MS; and Brian Jenssen, MD, MSHP; Mitesh Patel, MD, MBA, MS; Karen Glanz, PhD, MPH; Carmen Guerra, MD, MSCE; Katharine Nathanson, MD; Roy Rosin, MBA; and Kevin Volpp, MD, PhD.
For more information, click here to read the Penn Medicine press release.
Related News
PC3I News
PC3I and Tennessee Oncology’s McKay Institute for Oncology Transformation Unveil New Collaborative Relationship
02.06.2024
PC3I and Tennessee Oncology’s McKay Institute for Oncology Transformation announce an academic-community oncology innovation partnership to improve cancer care delivery.
PC3I News
PC3I Leadership Presents at 2023 AORTIC International Conference on Cancer in Africa
12.05.2023
PC3I Associate Director Surbhi Grover and Deputy Director Katharine Rendle presented research at the 14th AORTIC International Conference on Cancer in Africa, which took place in Dakar, Senegal.
PC3I News
2024 PC3I Innovation Accelerator Request for Proposals
11.10.2023
Through the Innovation Accelerator, the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center (ACC) invite applications for initiatives that aim to create and test innovative solutions to address challenges in productivity, efficiency, clinician wellbeing, or access in cancer care at Penn Medicine